SecurityIHE / iShares U.S. Pharmaceuticals ETF (464288836)
Institutional Owners96
Institutional Shares911,108
Institutional Value$ 142,375,000 USD

Institutional Stock Ownership and Shareholders

iShares U.S. Pharmaceuticals ETF (NYSE:IHE) has 96 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 911,108 shares. Largest shareholders include Morgan Stanley, Bank Of America Corp /de/, Brown Advisory Inc, Royal Bank Of Canada, Ameriprise Financial Inc, UBS Group AG, Murphy Capital Management Inc, Wells Fargo & Company/mn, Raymond James & Associates, and LPL Financial LLC.
iShares U.S. Pharmaceuticals ETF (NYSE:IHE) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-27 13F-HR TELEMUS CAPITAL, LLC 3,238 0 -100.00 500 0 -100.00
2018-05-14 13F-HR Acorn Wealth Advisors, Llc 806 765 -5.09 125 112 -10.40
2018-05-14 13F-HR BB&T SECURITIES, LLC 9,371 9,953 6.21 1,446 1,468 1.52
2018-05-09 13F-HR IFP Advisors, Inc 1,646 657 -60.09 254 97 -61.81
2018-05-02 13F-HR Creative Financial Designs Inc /adv 40 0 -100.00 6 0 -100.00
2018-02-14 13F-HR INVESTMENT CENTERS OF AMERICA INC 3,919 0 -100.00 614 0 -100.00
2018-05-15 13F-HR/A Kabarec Financial Advisors, Ltd. 125 144 15.20 19 21 10.53
2018-04-17 13F-HR Pinnacle Advisory Group, Inc. 3,701 3,526 -4.73 571 520 -8.93
2018-01-30 13F-HR ARKANSAS FINANCIAL GROUP, INC. 1,294 0 -100.00 202 0 -100.00
2018-05-14 13F-HR Virtu Financial LLC 2,474 0 -100.00 382 0 -100.00
2018-05-07 13F-HR Mawer Investment Management Ltd. 53,100 0 -100.00 8,198 0 -100.00
2018-04-19 13F-HR Janney Montgomery Scott LLC 2,032 1,641 -19.24 314 242 -22.93
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 38,569 6,703 -82.62 5,954 989 -83.39
2018-04-16 13F-HR WESPAC Advisors SoCal, LLC 0 212 0 31
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 4,613 4,613 0.00 712 681 -4.35
2018-05-10 13F-HR MCF Advisors LLC 14 14 0.00 2 2 0.00
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 10,152 10,012 -1.38 1,567 1,450 -7.47
2018-04-17 13F-HR MURPHY CAPITAL MANAGEMENT INC 28,157 27,665 -1.75 4,346 4,081 -6.10
2018-04-13 13F-HR Estate Counselors, LLC 0 2,300 0 339
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 2,500 0 -100.00 391 0 -100.00
2018-05-14 13F-HR BROWN ADVISORY INC 62,397 61,217 -1.89 9,633 9,032 -6.24
2018-05-15 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 90 0 -100.00 14 0 -100.00
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 35,297 39,720 12.53 5,449 5,833 7.05
2018-05-11 13F-HR HSBC HOLDINGS PLC 1,698 1,698 0.00 262 251 -4.20
2018-04-26 13F-HR Round Table Services, LLC 5,360 0 -100.00 827 0 -100.00
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 8,032 7,093 -11.69 1,240 1,047 -15.56
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 1,922 1,768 -8.01 297 261 -12.12
2018-04-17 13F-HR Sawyer & Company, Inc 143 143 0.00 22 21 -4.55
2018-05-10 13F-HR Capital Directions Investment Advisors, LLC 100 100 0.00 15 15 0.00
2018-05-09 13F-HR Transamerica Financial Advisors, Inc. 8 6 -25.00 2 1 -50.00
2018-02-02 13F-HR HUNTINGTON NATIONAL BANK 39 19 -51.28
2018-05-08 13F-HR US BANCORP \DE\ 669 669 0.00 103 99 -3.88
2018-05-18 13F-HR CIBC World Markets Inc. 1,550 1,550 0.00 239 229 -4.18
2018-05-02 13F-HR Clal Insurance Enterprises Holdings Ltd 750,000 0 -100.00 115,785 0 -100.00
2018-05-11 13F-HR Sigma Planning Corp 4,500 4,391 -2.42 695 648 -6.76
2018-04-23 13F-HR Financial Architects, Inc 379 380 0.26 58 56 -3.45
2018-05-11 13F-HR Cutler Group LP 600 0 -100.00 92 0 -100.00
2018-04-30 13F-HR BANK HAPOALIM BM 2,336 2,238 -4.20 361 330 -8.59
2018-05-11 13F-HR STIFEL FINANCIAL CORP 8,148 7,949 -2.44 1,257 1,173 -6.68
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 472 466 -1.27 73 69 -5.48
2018-05-15 13F-HR HPM Partners LLC 4,147 3,436 -17.14 640 507 -20.78
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 17,441 1,636 -90.62 2,693 241 -91.05
2018-05-15 13F-HR Asset Management Group, Inc. 6,282 6,305 0.37 970 930 -4.12
2018-04-25 13F-HR Bartlett & Co. LLC 30 30 0.00 5 4 -20.00
2018-05-03 13F-HR Texas Yale Capital Corp. 4,810 4,810 0.00 743 710 -4.44
2018-04-23 13F-HR Advisory Services Network, LLC 1,397 314 -77.52 216 46 -78.70
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,996 18,977 11.66 2,624 2,800 6.71
2018-05-10 13F-HR JP Morgan Chase & Co 7,045 7,695 9.23 1,088 1,135 4.32
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 22,754 20,910 -8.10 3,513 3,085 -12.18
2018-04-12 13F-HR Valeo Financial Advisors, Llc 414 414 0.00 64 61 -4.69
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 2,920 2,860 -2.05 451 422 -6.43
2018-05-08 13F-HR Karp Capital Management Corp 2,500 2,500 0.00 386 369 -4.40
2018-05-01 13F-HR OPPENHEIMER & CO INC 2,174 2,174 0.00 336 321 -4.46
2018-05-03 13F-HR Jacobi Capital Management LLC 110 110 0.00 17 16 -5.88
2018-04-09 13F-HR Koshinski Asset Management, Inc. 4,035 3,727 -7.63 623 550 -11.72
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 500 0 -100.00 77 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 1,600 4,100 156.25 247 605 144.94
2018-05-09 13F-HR AlphaMark Advisors, LLC 115 50 -56.52 18 7 -61.11
2018-05-03 13F-HR Essex Financial Services, Inc. 0 1,400 0 207
2018-05-14 13F-HR IHT Wealth Management, LLC 572 539 -5.77 89 76 -14.61
2018-05-14 13F-HR Pacific Sun Financial Corp 1,565 231
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 50 50 0.00 8 7 -12.50
2018-05-11 13F-HR CITIGROUP INC 835 335 -59.88 129 49 -62.02
2018-05-14 13F-HR Capital Analysts, Inc. 130 0 -100.00 20 0 -100.00
2018-04-12 13F-HR Bogart Wealth, Llc 21 0 -100.00 3 0 -100.00
2018-05-03 13F-HR SG Americas Securities, LLC 5,463 5,166 -5.44 843 762 -9.61
2018-04-19 13F-HR Asset Dedication, LLC 535 535 0.00 83 79 -4.82
2018-05-15 13F-HR Hilltop Holdings Inc. 5,343 0 -100.00 825 0 -100.00
2018-05-15 13F-HR LPL Financial LLC 21,545 23,344 8.35 3,326 3,444 3.55
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 6,286 2,883 -54.14 970 425 -56.19
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 28,831 26,308 -8.75 4,451 3,881 -12.81
2018-05-15 13F-HR Advisor Group, Inc. 1,997 1,997 0.00 309 295 -4.53
2018-01-26 13F-HR David R. Rahn & Associates Inc. 11,463 0 -100.00 1,792 0 -100.00
2018-04-09 13F-HR Founders Capital Management 284 284 0.00 44 42 -4.55
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 1,433 1,463 2.09 221 216 -2.26
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-04-16 13F-HR Westside Investment Management, Inc. 55 55 0.00 8,584 7,802 -9.11
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 61,066 52,591 -13.88 9,428 7,758 -17.71
2018-02-06 13F-HR Migdal Insurance & Financial Holdings Ltd. 3,535 0 -100.00 552 0 -100.00
2018-04-12 13F-HR Signature Wealth Management Group 311 311 0.00 48 46 -4.17
2018-04-05 13F-HR Edge Wealth Management LLC 1,109 1,109 0.00 171 164 -4.09
2018-02-15 13F-HR PVG ASSET MANAGEMENT CORP 5,385 0 -100.00 841,998 0 -100.00
2018-05-09 13F-HR Private Advisor Group, LLC 1,403 0 -100.00 219 0 -100.00
2018-05-15 13F-HR CAHILL FINANCIAL ADVISORS INC 7,843 7,100 -9.47 1,211 1,048 -13.46
2018-05-14 13F-HR BOKF, NA 1,928 1,928 0.00 298 284 -4.70
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 22,633 22,253 -1.68 3,511 3,480 -0.88
2018-05-14 13F-HR Aft, Forsyth & Company, Inc. 1,387 1,387 0.00 214 205 -4.21
2018-04-18 13F-HR Creative Planning 2,251 1,843 -18.13 347 272 -21.61
2018-05-01 13F-HR Wealthstreet Investment Advisors, Llc 3,689 5,095 38.11 570 752 31.93
2018-05-15 13F-HR JANE STREET GROUP, LLC 24,642 1,945 -92.11 3,804 287 -92.46
2018-02-07 13F-HR WHITTIER TRUST CO OF NEVADA INC 250 0 -100.00 39 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 3,500 7,100 102.86 540 1,048 94.07
2018-04-16 13F-HR SII INVESTMENTS INC/WI 7,676 0 -100.00 1,178 0 -100.00
2018-05-11 13F-HR First Allied Advisory Services, Inc. 2,263 2,147 -5.13 351 319 -9.12
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 21,573 24,295 12.62 3,330 3,584 7.63
2018-05-10 13F-HR SPINNAKER TRUST 16,839 16,397 -2.62 2,599 2,419 -6.93
2018-05-10 13F-HR TORONTO DOMINION BANK 830 0 -100.00 128 0 -100.00
2018-05-02 13F-HR Fusion Family Wealth LLC 170 170 0.00 26 25 -3.85
2018-02-13 13F-HR BANK OF NOVA SCOTIA TRUST CO 80 0 -100.00 13 0 -100.00
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 621 528 -14.98 96 78 -18.75
2018-04-18 13F-HR REGIONS FINANCIAL CORP 180 180 0.00 28 27 -3.57
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 4,204 3,891 -7.45 649 574 -11.56
2018-04-20 13F-HR Pratt Collard Advisory Partners Llc 2,300 2,300 0.00 355 339 -4.51
2018-05-10 13F-HR Financial Partners Group, Inc 18,547 14,275 -23.03 2,863 2,106 -26.44
2018-05-09 13F-HR Cetera Advisor Networks LLC 10,016 9,687 -3.28 1,547 1,429 -7.63
2018-02-01 13F-HR Tradewinds Capital Management, LLC 24 0 -100.00 4 0 -100.00
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 3,323 3,323 0.00 513 490 -4.48
2018-04-25 13F-HR TOTH FINANCIAL ADVISORY CORP 1,478 1,530 3.52 228 226 -0.88
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 81,947 66,568 -18.77 12,652 9,821 -22.38
2018-04-26 13F-HR Family Firm, Inc. 1,757 2,415 37.45 271 356 31.37
2018-05-03 13F-HR Bedel Financial Consulting, Inc. 425 63
2018-04-20 13F-HR PATTEN & PATTEN INC/TN 8,145 8,060 -1.04 1,257 1,189 -5.41
2018-05-08 13F-HR SIGNATUREFD, LLC 0 50 0 7
2018-04-25 13F-HR Raab & Moskowitz Asset Management LLC 3,540 3,557 0.48 546 524 -4.03
2018-05-03 13F-HR COMMERCE BANK 1,754 1,754 0.00 271 259 -4.43
2018-05-14 13F-HR MORGAN STANLEY 262,267 281,591 7.37 40,488 41,546 2.61
2018-04-26 13F-HR DUNCKER STREETT & CO INC 100 100 0.00 15 15 0.00
2018-05-15 13F-HR UBS Group AG 16,400 32,107 95.77 2,531 4,737 87.16
2018-04-30 13F-HR Certified Advisory Corp 60 0 -100.00 9 0 -100.00
2018-05-15 13F-HR EDMOND DE ROTHSCHILD HOLDING S.A. 100 100 0.00 15 15 0.00
2018-05-14 13F-HR Clear Perspective Advisors, LLC 800 350 -56.25 124 52 -58.06
2018-04-17 13F-HR Calton & Associates, Inc. 58 0 -100.00 9 0 -100.00
2018-05-23 13F-HR Bdo Wealth Advisors, Llc 0 140 0 21
2018-03-14 13F-HR/A CREDIT SUISSE AG/ 38,844 0 -100.00 6,074 0 -100.00
2018-05-15 13F-HR FIFTH THIRD BANCORP 90 140 55.56 14 21 50.00

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

Related News Stories

Q1 Earnings Drag Pharma ETFs Down

2018-05-04 zacks
Total earnings for 83.1% of the total healthcare market capitalization are up 14.7% on revenue growth of 8.1%. The growth rates seem unimpressive when compared with some of the other sectors. Earnings and revenue beat ratios of 88.9% and 75%, respectively, are also not great either. Among the most notable players, Johnson & Johnson (JNJ - Free Report) was the first major drug company to report earnings on Apr 17, followed by Eli Lilly and Company (LLY - Free Report) and Bristol-Myers Squibb Company (BMY - Free Report) on Apr 24 and Apr 26, respectively. (11-0)

Is SPDR S&P Pharmaceuticals ETF (XPH) a Hot ETF Right Now?

2018-04-24 zacks
A smart beta exchange traded fund, the SPDR S&P Pharmaceuticals ETF (XPH - Free Report) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the U.S. equity market. (128-0)

Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

2018-04-24 zacks
If you're interested in broad exposure to the Healthcare - Pharma segment of the U.S. equity market, look no further than the VanEck Vectors Pharmaceutical ETF (PPH - Free Report) , a passively managed exchange traded fund launched on 12/20/2011. (102-0)

Solid Q4 Earnings Drive Pharma ETF Outlook

2018-02-09 zacks
Total earnings for 86.8% of the total healthcare market capitalization are up 8.2% on revenue growth of 6.5%. Not only are the growth rates impressive, the earnings and revenues beat ratios of 83.8% and 86.5%, respectively, are great too. The robust numbers have pushed healthcare stocks higher by an average 1.2% against the 0.2% gain for the S&P 500 in response to earnings announcements. Among the most notable players, Johnson & Johnson (JNJ - Free Report) was the first major drug company to report earnings on Jan 23, followed by Pfizer (PFE - Free Report) and Eli Lilly and Company (LLY - Free Report) on Jan 30 and Jan 31, respectively. (11-0)

Healthcare ETFs in Focus Post JNJ Q4 Results

2018-01-24 zacks
The Q4 earnings season has commenced and Johnson & Johnson (JNJ - Free Report) was the first drug company to report on Jan 23, before the opening bell. The world's biggest maker of health care products continued its long streak of earnings beat and offered a decent outlook for 2018. Earnings per share came in at $1.74, a couple of cents ahead of the Zacks Consensus Estimate and 10.1% higher than the year-ago quarter. (5-0)

CUSIP: 464288836